IBD: More Patients on Vedolizumab vs Anti-TNFs at 2 Years ...Middle East

Vedolizumab showed a higher overall 1- and 2-year persistence of use compared with two anti–tumor necrosis factor inhibitors in both Crohn's disease and ulcerative colitis. MDedge News

Hence then, the article about ibd more patients on vedolizumab vs anti tnfs at 2 years was published today ( Saturday 04/03/2023 - 12:21 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IBD: More Patients on Vedolizumab vs Anti-TNFs at 2 Years )

Also on site :

• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
• Saks Global Secures $1.75 Billion of Committed Capital and Announces Return of Industry Veterans to Advance Transformation of Iconic Luxury Portfolio